IntroductionThe study investigation examined the immune response to the Janssen Ad26. COV2. S COVID-19 vaccine within a Ugandan cohort. specifically targeting antibodies directed against spike (S) and nucleocapsid (N) proteins. https://www.roneverhart.com/Carin-Shard-East-Non-Ladder/